May/June 2015

Contribution of Phone Follow-up to Improved Adherence to Oral Osteoporosis Treatment

July 30, 2015

The American Journal of Pharmacy Benefits

The authors studied the usefulness of a regular telephone follow-up to improve adherence to oral antiosteoporosis treatments. Their results support such follow-up and the use of this strategy in routine clinical practice.

Demographic Characteristics of Asthma Subjects Associated With Stepping Down From Fluticasone Propionate/Salmeterol Combination Therapy

July 29, 2015

The American Journal of Pharmacy Benefits

Patients on fluticasone propionate/salmeterol maintenance therapy who have more frequent physician interactions, especially interactions with asthma specialists, may be more likely have their controller medication reduced.

A Multi-Pronged Approach to Addressing the Opioid Epidemic

July 10, 2015

The American Journal of Pharmacy Benefits

The opioid epidemic in the United States is a critical public health issue that requires a multi-stakeholder, multi-pronged approach to mitigate its devastating outcomes.

Opioid-Induced Constipation: Considerations for Formulary Decision Makers

June 19, 2015

The American Journal of Pharmacy Benefits

This activity reviews the incidence and impact of opioid-induced constipation (OIC), discusses available treatment options, and what factors should be considered during formulary decisions for OIC.

Rethinking Pharmacy Employee Engagement

June 18, 2015

The American Journal of Pharmacy Benefits

While often overlooked, employee engagement is a key element in determining whether a hospital, health system, or pharmacy service can effectively meet its patient access, patient quality, and organizational financial demands.

Impact of Co-Payment Discounts on Antidepressant Medication Adherence and Costs

June 17, 2015

The American Journal of Pharmacy Benefits

A unique co-payment discount program for antidepressants was associated with higher antidepressant medication adherence, lower likelihood of discontinuation, and lower healthcare costs.

Annual Stroke Costs to Health Plans Among Atrial Fibrillation Patients

June 17, 2015

The American Journal of Pharmacy Benefits

An incidence-based model was developed to estimate the annual ischemic and hemorrhagic stroke–related healthcare costs to a hypothetical US health plan with 1 million enrollees.